Works by Gun Min Kim


Results: 41
    1
    2
    3
    4

    Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 1, p. 123, doi. 10.4143/crt.2021.1561
    By:
    • Jieun Lee;
    • Keun Seok Lee;
    • Sung Hoon Sim;
    • Heejung Chae;
    • Joohyuk Sohn;
    • Gun Min Kim;
    • Kyung-Hee Lee;
    • Su Hwan Kang;
    • Kyung Hae Jung;
    • Jae-ho Jeong;
    • Jae Ho Byun;
    • Su-Jin Koh;
    • Kyoung Eun Lee;
    • Seungtaek Lim;
    • Hee Jun Kim;
    • Hye Sung Won;
    • Hyung Soon Park;
    • Guk Jin Lee;
    • Soojung Hong;
    • Sun Kyung Baek
    Publication type:
    Article
    5
    6
    7
    8

    Age- and ethnic-driven molecular and clinical disparity of East Asian breast cancers.

    Published in:
    BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03638-y
    By:
    • Lee, Ji Yoon;
    • Lee, Ji Won;
    • Chung, Min Sung;
    • Choi, Jong Gwon;
    • Sim, Sung Hoon;
    • Kim, Hyo Jeong;
    • Kim, Jeong Eun;
    • Lee, Kyoung Eun;
    • Park, Yeon Hee;
    • Kang, Myoung Joo;
    • Ahn, Mi Sun;
    • Chae, Yee Soo;
    • Park, Ji Hyun;
    • Kim, Jee Hyun;
    • Kim, Gun Min;
    • Byun, Jae Ho;
    • Park, Keon Uk;
    • Kim, Ju Won;
    • Jung, Seung Pil;
    • Lee, Jung Hyun
    Publication type:
    Article
    9
    10

    Genomic landscape of extraordinary responses in metastatic breast cancer.

    Published in:
    Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-01973-x
    By:
    • Lim, Sun Min;
    • Kim, Eunyoung;
    • Jung, Kyung Hae;
    • Kim, Sora;
    • Koo, Ja Seung;
    • Kim, Seung Il;
    • Park, Seho;
    • Park, Hyung Seok;
    • Park, Byoung Woo;
    • Cho, Young Up;
    • Kim, Ji Ye;
    • Paik, Soonmyung;
    • Kwon, Nak-Jung;
    • Kim, Gun Min;
    • Kim, Ji Hyoung;
    • Kim, Min Hwan;
    • Jeon, Min Kyung;
    • Kim, Sangwoo;
    • Sohn, Joohyuk
    Publication type:
    Article
    11
    12
    14
    15
    16
    17
    18

    Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1036, doi. 10.1093/jnci/djad080
    By:
    • Kim, Min Hwan;
    • Kim, Gun Min;
    • Ahn, Jin Mo;
    • Ryu, Won-Ji;
    • Kim, Seul-Gi;
    • Kim, Jee Hung;
    • Kim, Tae Yeong;
    • Han, Hyun Ju;
    • Kim, Jee Ye;
    • Park, Hyung Seok;
    • Park, Seho;
    • Park, Byeong Woo;
    • Kim, Seung Il;
    • Jeong, Joon;
    • Lee, Jieun;
    • Paik, Soonmyung;
    • Kim, Sangwoo;
    • Jung, Kyung Hae;
    • Cho, Eun Hae;
    • Sohn, Joohyuk
    Publication type:
    Article
    19
    20
    21

    Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37768-3
    By:
    • Bae, Mingyun;
    • Kim, Gyuhee;
    • Lee, Tae-Rim;
    • Ahn, Jin Mo;
    • Park, Hyunwook;
    • Park, Sook Ryun;
    • Song, Ki Byung;
    • Jun, Eunsung;
    • Oh, Dongryul;
    • Lee, Jeong-Won;
    • Park, Young Sik;
    • Song, Ki-Won;
    • Byeon, Jeong-Sik;
    • Kim, Bo Hyun;
    • Sohn, Joo Hyuk;
    • Kim, Min Hwan;
    • Kim, Gun Min;
    • Chie, Eui Kyu;
    • Kang, Hyun-Cheol;
    • Kong, Sun-Young
    Publication type:
    Article
    22
    23
    24

    Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10).

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3265, doi. 10.3390/cancers12113265
    By:
    • Lee, Soohyeon;
    • Im, Seock-Ah;
    • Kim, Gun Min;
    • Jung, Kyung Hae;
    • Kang, Seok Yun;
    • Park, In Hae;
    • Kim, Jee Hyun;
    • Lee, Kyoung Eun;
    • Ahn, Hee Kyung;
    • Lee, Moon Hee;
    • Kim, Hee-Jun;
    • Kim, Han Jo;
    • Lee, Jong In;
    • Koh, Su-Jin;
    • Park, Yeon Hee
    Publication type:
    Article
    25
    26

    First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors.

    Published in:
    Investigational New Drugs, 2022, v. 40, n. 5, p. 1001, doi. 10.1007/s10637-022-01277-9
    By:
    • Janku, Filip;
    • Beom, Seung-Hoon;
    • Moon, Yong Wha;
    • Kim, Tae Won;
    • Shin, Young G.;
    • Yim, Dong-Seok;
    • Kim, Gun Min;
    • Kim, Hyo Song;
    • Kim, Sun Young;
    • Cheong, Jae-Ho;
    • Lee, Young Woo;
    • Geiger, Barb;
    • Yoo, Sanghee;
    • Thurston, Archie;
    • Welsch, Dean;
    • Rudoltz, Marc S.;
    • Rha, Sun Young
    Publication type:
    Article
    27
    28
    29
    30

    A phase II trial of the pan‐HER inhibitor poziotinib, in patients with HER2‐positive metastatic breast cancer who had received at least two prior HER2‐directed regimens: results of the NOV120101‐203 trial.

    Published in:
    International Journal of Cancer, 2018, v. 143, n. 12, p. 3240, doi. 10.1002/ijc.31651
    By:
    • Park, Yeon Hee;
    • Lee, Kyung‐Hun;
    • Sohn, Joo Hyuk;
    • Lee, Keun Seok;
    • Jung, Kyung Hae;
    • Kim, Jee‐Hyun;
    • Lee, Ki Hyeong;
    • Ahn, Jin Seok;
    • Kim, Tae‐Yong;
    • Kim, Gun Min;
    • Park, In Hae;
    • Kim, Sung‐Bae;
    • Kim, Se Hyun;
    • Han, Hye Sook;
    • Im, Young‐Hyuck;
    • Ahn, Jin‐Hee;
    • Kim, Jung‐Yong;
    • Kang, Jahoon;
    • Im, Seock‐Ah
    Publication type:
    Article
    31

    CUMULATIVE IMPACT DAMAGE EVALUATION OF AUTOMOTIVE ALUMINUM BUMPER BEAM.

    Published in:
    International Journal of Modern Physics B: Condensed Matter Physics; Statistical Physics; Applied Physics, 2008, v. 22, n. 9-11, p. 1584, doi. 10.1142/S0217979208047110
    By:
    • HEON YOUNG KIM;
    • JONG GIL CHOI;
    • MIN GUN KIM;
    • KANG WOOK LEE;
    • DAE YUL HA;
    • TAE JUNG YEO
    Publication type:
    Article
    32
    33

    A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer.

    Published in:
    NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00684-w
    By:
    • Noguchi, Emi;
    • Yamanaka, Takashi;
    • Mukai, Hirofumi;
    • Yamamoto, Naohito;
    • Chung, Chi-Feng;
    • Lu, Yen-Shen;
    • Chang, Dwan-Ying;
    • Sohn, Joohyuk;
    • Kim, Gun Min;
    • Lee, Kyung-Hun;
    • Lee, Soo-Chin;
    • Iwasa, Tsutomu;
    • Iwata, Hiroji;
    • Watanabe, Kenichi;
    • Jung, Kyung Hae;
    • Tanabe, Yuko;
    • Kang, Seok Yun;
    • Yasojima, Hiroyuki;
    • Aogi, Kenjiro;
    • Tokunaga, Eriko
    Publication type:
    Article
    34
    35

    On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates.

    Published in:
    Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-022-01601-4
    By:
    • Kim, Chang Gon;
    • Kim, Min Hwan;
    • Kim, Jee Hung;
    • Kim, Seul-Gi;
    • Kim, Gun Min;
    • Kim, Tae Yeong;
    • Ryu, Won-Ji;
    • Kim, Jee Ye;
    • Park, Hyung Seok;
    • Park, Seho;
    • Cho, Young Up;
    • Park, Byeong Woo;
    • Kim, Seung Il;
    • Jeong, Joon;
    • Sohn, Joohyuk
    Publication type:
    Article
    36
    37
    38
    39
    40
    41